Magnetic resonance microscopy maps widespread effects of Alzheimer’s disease on brain structures and behavior in mice
Open accessAbstract
Alzheimer's disease has widespread effects on brain structure, function and behavior, but we lack a systematic dissection of its impact across hundreds of forebrain and brainstem regions. Here, using diffusion tensor MRI at 25 µm, we mapped the global consequences of mutations in APP and PSEN1 across 231 regions of interest (ROIs) in male and female 5×FAD BXD hybrid mice at 14 months. Over half of the ROIs change in volume along rostrocaudal and mediolateral axes of the CNS, with unexpected swelling in the neocortex, hippocampus and amygdala of up to 10%, counterbalanced by shrinkage in the thalamus, brainstem and most white matter tracts. Yet, total brain volume is unaltered. Variation in individual ROI volumes is highest in females. Differences in fear acquisition and contextual memory performance covary with volumes of several regions and can have opposite polarities between cases and controls. These structural benchmarks establish a foundation for testing therapeutic interventions in preclinical trials.
AI snapshot
Written from the paper’s full text.
TL;DR
This study used 25 μm diffusion tensor MRI to map 5×FAD Alzheimer’s disease mutations across 231 CNS regions in genetically diverse AD-BXD F1 mice at 14 months. It found widespread regional volume changes—rostral enlargement and caudal shrinkage—without altering total brain size, with effects modulated by genetic background and sex and correlated with fear learning/memory measures.
Key findings
- Of 231 ROIs, 137 had significant volume changes as a percentage of total brain volume at FDR <0.05; total brain volume did not differ significantly between cases and controls (475.7 ± 3.7 mm³ vs 477.8 ± 6.0 mm³, s.e.).
- Effects followed a rostrocaudal gradient: telencephalic grey matter structures such as neocortex, hippocampus, and amygdala increased in volume by up to 10%, while thalamus, brainstem, and most fiber tracts decreased; the corticospinal tract lost up to 8.1% volume and 11% fractional anisotropy.
- Genetic background explained 23% of variance in fractional volume across all ROIs and 20% for the 137 significant ROIs; sex explained about 7%, with 123 ROIs significant in females and 93 in males.
- Behavioral covariation was detected: 29 ROIs correlated with contextual fear acquisition at PBH <0.05 and 9 with contextual fear memory; case-control correlation polarity differences were nominally significant for 46 ROIs with fear acquisition but none survived FDR correction.
Methods
- Case-control design using four AD-BXD F1 hybrid types (AD-BXD32, AD-BXD65, AD-BXD77, AD-BXD101) at 14 months: 57 mice total, including 34 5×FAD cases and 23 controls, with 26 males and 31 females.
- Ex vivo diffusion tensor MRI at 25 μm isotropic resolution with 61 diffusion angles, gadolinium contrast, and automated alignment to CCFv3/DMBA atlases; 230 ROIs plus whole brain were delineated bilaterally, with right-left coefficient of variation averaging 1.8%.
- Behavioral testing included contextual fear acquisition and contextual fear memory for 52 of 57 mice; a subset of AD-BXD77 F1 mice underwent light-sheet microscopy and stereology for Aβ and NeuN. Analyses used ANOVA on fractional ROI volumes with Benjamini-Hochberg or Bonferroni correction, Levene’s and Welch’s tests, and Spearman/Pearson correlations.
Limitations
- The paper states that case-control correlation analyses had modest sample sizes (31 cases and 21 controls) and were not well powered; no case-control correlation differences survived FDR correction, and no transgene-by-background or sex-by-transgene interactions survived multiple-test correction.
- Stated technical caveats include possible antibody penetration/specificity issues in light-sheet stereology, an implausible increase in NeuN+ cells in visual cortex that may reflect sampling error or nonspecific labeling, and possible common antibody penetration patterns driving Aβ–NeuN correlations.
- The text notes that 5×FAD does not model late-stage human AD well, particularly tau tangle formation, and that translational relevance of the model remains controversial; the study is also cross-sectional at 14 months and uses only four AD-BXD F1 types for the main volumetric analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
56 of 74 cited sources checked · 16 supported · 0 flagged · accuracy not yet measured
- Study design and conductown data
The right-left dissection replicability provides sufficient precision to detect much smaller volume differences than in previous work.
“This level of right-left dissection replicability provides sufficient precision to detect much smaller volume differences than in previous work33.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Crombé, A., Nicolas, R., Richard, N., Tourdias, T. & Hiba, B. High B-value diffusion tensor imaging for early detection of hippocampal microstructural alteration in a mouse model of multiple sclerosis. Sci. Rep. 12, 12008 (2022). source
The Materials and methods (Data analysis; page unavailable) describes delineating hippocampal regions on MRI images, not right-left physical dissection. The Results (Quality control—SNR and CNR; page unavailable) discusses image quality, but our copy provides no right-left dissection replicability measure or comparison of detectable volume differences with previous work. Searches for those terms found no supporting passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Study design and conductcitation
Light-sheet stereology gained accuracy because the diffeomorphic alignment used corrects for tissue distortions during whole-brain tissue clearing.
“Light-sheet stereology also gained accuracy because the diffeomorphic alignment that we use corrects for tissue distortions that occur during whole-brain tissue clearing31.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] Mansour, H. et al. The Duke Mouse Brain Atlas: MRI and light sheet microscopy stereotaxic atlas of the mouse brain. Sci. Adv. 11, eadq8089 (2025). source
- Interpretationown data
This set highlights many sensory, perceptual, and motor systems critical for fear conditioning.
“Collectively, this set highlights many sensory, perceptual, and motor systems critical for fear conditioning54-57.”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [54] Gusel’nikova, V. V. & Korzhevskiy, D. E. NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae 7, 42–47 (2015). source
The Introduction discusses NeuN as a neuronal marker and mentions some motor neurons, but it does not describe a set of sensory, perceptual, and motor systems or their role in fear conditioning. Searches for fear conditioning and for sensory and motor systems found no passage addressing that claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [55] Greco, J. A. & Liberzon, I. Neuroimaging of fear-associated learning. Neuropsychopharmacology 41, 320–334 (2016). source
- cites [56] Antoniadis, E. A. & McDonald, R. J. Amygdala, hippocampus and discriminative fear conditioning to context. Behav. Brain Res. 108, 1–19 (2000). source
- cites [57] Keifer, O. P. Jr., Hurt, R. C., Ressler, K. J. & Marvar, P. J. The physiology of fear: reconceptualizing the role of the central amygdala in fear learning. Physiology 30, 389–401 (2015). source
- Findingreasoning
Our positive findings contrast sharply with negative findings of the MODEL-AD consortium and other recent studies that have also used T1/T2 MRI and DTI methods.
“Our positive findings contrast sharply with negative findings of the MODEL-AD consortium16 and other recent studies that have also used T1/T2 MRI and DTI methods7,44 (Supplementary Tables 2 and 3).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [16] Oblak, A. L. et al. Comprehensive evaluation of the 5×FAD mouse model for preclinical testing applications: a MODEL-AD study. Front. Aging Neurosci. 13, 713726 (2021). source
The Materials and Methods section (Magnetic Resonance Imaging; page unavailable) confirms that this MODEL-AD study acquired T2-weighted MRI images. The cited passages do not report negative T1/T2 MRI or DTI findings: they describe T2 imaging for the PET/MRI work, while the Results report PET-detected changes. Thus the citation supports the study identification and T2 use, but not the attributed negative findings or use of T1 and DTI. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [7] Murdy, T. J. et al. Leveraging genetic diversity in mice to inform individual differences in brain microstructure and memory. Front. Behav. Neurosci. 16, 1033975 (2022). source
- cites [44] Andersen, J. V. et al. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5×FAD mouse model of Alzheimer’s disease. Cell Death Dis. 12, 954 (2021). source
The Materials and methods sections describe metabolic, proteomic, and electron-microscopy analyses, not T1/T2 MRI or DTI. The Discussion passage on regional brain metabolism does not report negative MRI findings or discuss the MODEL-AD consortium. Searches for those terms found no passage in our copy that addresses the attributed claim; page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingcitation
Regions with higher mean activity and glucose demands tend to match those ROIs that swell.
“Regions with higher mean activity and glucose demands tend to match those ROIs that swell.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [49] Evangelio, M., García-Amado, M. & Clascá, F. Thalamocortical projection neuron and interneuron numbers in the visual thalamic nuclei of the adult C57BL/6 mouse. Front. Neuroanat. 12, 27 (2018). source
The Results section on dLGN and LP complex volume reports anatomical volume differences, not swelling of regions with higher mean activity or glucose demand. The Discussion section on volume speculates that the larger left dLGN might reflect lateralized sensory use, but does not test the claimed relationship. Searches for glucose metabolism, activity and swelling found no passage addressing it; page numbers were not available in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [50] Eimer, W. A. & Vassar, R. Neuron loss in the 5×FAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Mol. Neurodegener. 8, 2 (2013). source
The Results sections on Caspase-3 activation and Aβ42 deposition describe where neuronal degeneration occurs in 5XFAD mice, not which regions swell. Searches for regional activity, glucose demand, and swelling found no passage in our copy linking these measures. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Interpretationcitation
The prominence of thalamic ROIs is consistent with their roles in AD.
“The prominence of thalamic ROIs is consistent their roles in AD67,68,69.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [67] Aggleton, J. P., Pralus, A., Nelson, A. J. & Hornberger, M. Thalamic pathology and memory loss in early Alzheimer’s disease: moving the focus from the medial temporal lobe to Papez circuit. Brain 139, 1877–1890 (2016). source
- cites [68] Braak, H. & Braak, E. Alzheimer’s disease affects limbic nuclei of the thalamus. Acta Neuropathol. 81, 261–268 (1991). source
- cites [69] Forno, G. et al. Thalamic nuclei changes in early and late onset Alzheimer’s disease. Curr. Res. Neurobiol. 4, 100084 (2023). source
- Premisecitation
Expression of the bigenic 5×FAD transgene is driven by neuron-specific Thy1 cassette vectors.
“Expression of the bigenic 5×FAD transgene is driven by neuron-specific Thy1 cassette vectors81.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [81] Avants, B. B. et al. The Insight ToolKit image registration framework. Front. Neuroinform. 8, 44 (2014). source
The Results section (3.2, Evaluation) discusses MRI image registration and brain labeling, not transgene expression. Searches of our copy for 5×FAD, Thy1, and neuron-specific transgene vectors found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Study design and conductcitation
Densities of aβ plaques and NeuN+ cells can be estimated in anatomically corrected stereotaxic space using a digital version of direct 3-dimensional counting (optical disector).
“We can estimate densities of aβ plaques and NeuN+ cells in anatomically corrected stereotaxic space using a digital version of direct 3-dimensional counting, now often referred to as the optical disector23,99.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [23] Tian, Y., Johnson, G. A., Williams, R. W. & White, L. A rapid workflow for neuron counting in combined light sheet microscopy and magnetic resonance histology. Front. Neurosci. 17, 1223226 (2023). source
The Abstract (page not specified) describes deformation-corrected NeuN densities and automated sampling and counting in 3D volumes; the Discussion says densities are calculated in morphology-corrected space. The paper does not report aβ-plaque densities or identify its digital workflow as an optical disector, so those parts of the attributed claim are unsupported. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [99] Sloan, Z. et al. GeneNetwork: framework for web-based genetics. J. Open Source Softw. https://doi.org/10.21105/joss.00025 (2016). source
The main GeneNetwork section describes web-based genetic mapping and analysis, not anatomical cell or plaque counting. Searches for optical disector, NeuN, amyloid plaques, stereotaxic space, and digital stereology found no passage addressing the claimed method; the copy provides neither support nor a contrary finding. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Rests on an assumption: The DMBA coordinate space is a consensus for the C57BL/6J strain at stereotaxic precision.
- Interpretationcitation
The possibility that rostral-to-caudal effects are downstream of regional differences in promoter activity can probably be ruled out because many teams have shown strong expression of the transgene and high levels of amyloid plaque deposition in thalamus and midbrain.
“This raises the possibility that rostral-to-caudal effects we have detected are downstream of regional differences in promoter activity. This can probably be ruled out because many teams have shown strong expression of the transgene and high levels of amyloid plaque deposition in thalamus and midbrain81—regions in which we have demonstrated highly significant reductions in volume (Ref20, their”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [81] Avants, B. B. et al. The Insight ToolKit image registration framework. Front. Neuroinform. 8, 44 (2014). source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [20] Forner, S. et al. Systematic phenotyping and characterization of the 5×FAD mouse model of Alzheimer’s disease. Sci. Data 8, 270 (2021). source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [16] Oblak, A. L. et al. Comprehensive evaluation of the 5×FAD mouse model for preclinical testing applications: a MODEL-AD study. Front. Aging Neurosci. 13, 713726 (2021). source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Interpretationcitation
The use of diverse AD-BXD F1 models avoids the risk of idiosyncratic effects caused by studying mutations and other transgenes on a single genetic background.
“On a positive note, the use of diverse AD-BXD F1 models10 avoids the risk of idiosyncratic effects caused by studying mutations and other transgenes on a single genetic background.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [10] Neuner, S. M., Heuer, S. E., Huentelman, M. J., O’Connell, K. M. S. & Kaczorowski, C. C. Harnessing genetic complexity to enhance translatability of Alzheimer’s disease mouse models: a path toward precision medicine. Neuron 101, 399–411 (2019). source
- Premisecitation
The 5×FAD transgene does not trigger the late phase formation of neurofibrillary (tau) tangles.
“In particular, the 5×FAD transgene does not trigger the late phase formation of neurofibrillary (tau) tangles (but see Ref77).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [77] Shin, J., Park, S., Lee, H. & Kim, Y. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5×FAD transgenic mouse model. Sci. Rep. 11, 1617 (2021). source
The Introduction says 5XFAD was designed to develop amyloid pathology, and the Discussion says significant tauopathy was not expected. But the Results report phosphorylated tau aggregates, and the Discussion says further study is needed to determine whether they are neurofibrillary tangles. The paper therefore does not establish the claim that the transgene does not trigger late-phase tangle formation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The expression of Aβ42 plaques in humans with highly penetrant APP and PSEN mutations occurs as much as 10-20 years before serious cognitive loss.
“In defense of this strategy, the expression of Aβ42 plaques in humans with highly penetrant APP and PSEN mutations occurs as much as 10–20 years before serious cognitive loss75,76, so in this regard the temporal dynamics of the 5×FAD mouse is actually a reasonable match to prodromal autosomal dominant forms of AD in humans.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [75] Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N. Engl. J. Med. 367, 795–804 (2012). source
The Results (Aβ Deposition and Combined Model; page unavailable) report fibrillar Aβ deposition in mutation carriers 15 years before expected symptom onset, preceding global cognitive impairment by about 10 years. The paper separately reports declining CSF Aβ42, but does not identify the PET-detected deposits specifically as Aβ42 plaques. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [76] Gordon, B. A. et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: a longitudinal study. Lancet Neurol. 17, 241–250 (2018). source
The Abstract Findings report that Aβ deposition in mutation carriers diverged from non-carriers an average of 18.9 years before expected symptom onset, and the Methods identify carriers of APP and PSEN mutations. However, the study measured Aβ deposition with PiB PET, not Aβ42 plaques specifically, and its timing is relative to expected symptom onset rather than measured serious cognitive loss. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationcitation
5×FAD models are particularly suitable for dissecting earlier mechanisms, processes, and for testing early therapeutic interventions relevant to prodromal human AD.
“In summary, 5×FAD models are particularly suitable for dissecting earlier mechanisms, processes, and for testing early therapeutic interventions relevant to prodromal human AD, a case recently also made by Jucker and colleagues78,79.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [78] Rother, C. et al. Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae. Nat. Commun. 13, 7333 (2022). source
The Discussion describes APP-transgenic mice as models of presymptomatic AD and argues for earlier Aβ-targeting intervention. But the Methods (Experimental animals; BACE1 inhibitor treatment) identify APPPS1 and APP23 mice, not 5×FAD mice. The paper supports the broader rationale for studying early disease and interventions in mouse models, but not the claim that 5×FAD is particularly suitable. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [79] Jucker, M. & Walker, L. C. Alzheimer’s disease: from immunotherapy to immunoprevention. Cell 186, 4260–4270 (2023). source
- Findingown data
There is a 25.1 ± 3.9% reduction in NeuN+ cells in the parafascicular thalamic nucleus (PFT) of AD-BXD77 F1 cases (PBH = 0.1).
“and a 25.1 ± 3.9% reduction in the parafascicular thalamic nucleus (PFT, PBH = 0.1).”
Quote in the paperNot a substantial claim - Findingown data
Fractional anisotropy of corticofugal projections is reduced by 11% in 5×FAD cases.
“and a loss of 11% in fractional anisotropy (Fig. 6i, Supplementary Table 9c).”
Quote in the paperNot a substantial claim - Findingown data
Effect sizes of 5×FAD on ROI volumes are modest in absolute terms, in most cases less than ±10%.
“Effect sizes are modest in absolute terms, in most cases less than ±10%.”
Quote in the paperNot a substantial claim - Findingown data
The top ten ROIs for CFA ranked by significance are VMT, TPA, ZIN, SUT, lbu, PFT, THA, MRN, DIE, and RED-all thalamic or rostral midbrain structures or tracts.
“The top ten for CFA ranked by significance are VMT, TPA, ZIN, SUT, lbu, PFT, THA, MRN, DIE, and RED—all of which are thalamic or rostral midbrain structures or tracts.”
Quote in the paperNot a substantial claim - Findingown data
The 5×FAD transgene has no significant effect on total brain volume in AD-BXD F1 mice at 14 months of age.
“There is no global effect of the 5×FAD transgene on total brain volume in AD-BXD F1 mice at 14 months of age.”
- Also stated in: § No effects of 5×FAD mutation on total brain volume on any of four genetic backgrounds · plain
“Volumes of transgenic cases and their controls do not differ significantly—475.7 ± 3.7 mm3 (s.e.) and 477.8 ± 6.0 mm3 (s.e.), respectively.”
- Also stated in: § No effects of 5×FAD mutation on total brain volume on any of four genetic backgrounds · plain
“Even when stratified by the four F1 hybrid types we studied—AD-BXD32 F1, AD-BXD65 F1, AD-BXD77 F1, and AD-BXD101 F1—there are still no differences in brain size between cases and controls.”
Quote in the paperSubstantial claim - Also stated in: § No effects of 5×FAD mutation on total brain volume on any of four genetic backgrounds · plain
- Findingown data
The Fisher's combined P value for the increase in volumes of telencephalic ROIs is highly significant (P < 0.0001).
“The Fisher’s combined P value of this increase in volumes of telencephalic ROIs is highly significant even given the marked reduction in power by testing a single AD-BXD F1 type (P < 0.0001; Supplementary Table 9b).”
Quote in the paperSubstantial claim - Findingown data
There is a 36.6 ± 3.9% reduction in NeuN+ cells in the anteroventral thalamic nucleus (AVT) of AD-BXD77 F1 cases (PBH = 0.03).
“More specifically there is a 36.6 ± 3.9% reduction in the anteroventral thalamic nucleus (AVT, PBH = 0.03)”
Quote in the paperSubstantial claim - Findingown data
Strain genetic background has a very strong effect on total brain volume in AD-BXD F1 mice (PBH <3e-7).
“In contrast, there is a very strong effect of strain genetic background of these F1 hybrids on brain volume (PBH <3e–7).”
Quote in the paperSubstantial claim - Findingown data
There is a positive correlation of r = 0.49 between volume of the fimbria (fim) and better contextual fear acquisition (CFA) performance.
“Fig. 7a highlights a positive correlation of r = 0.49 between volume of the fimbria (fim) and better CFA performance”
Quote in the paperNot a substantial claim - Findingown data
Of all structures, only the thalamus and its polymodal association regions (TPA) are significantly correlated with both contextual fear acquisition and contextual fear memory.
“Of all structures, only the thalamus and its polymodal association regions (TPA) are significantly correlated with both of these memory functions.”
Quote in the paperSubstantial claim - Findingown data
There is reasonably good evidence for a loss of NeuN-positive cells in hippocampus of AD-BXD77 F1 cases.
“There is reasonably good evidence for a loss of NeuN-positive cells—almost exclusively neurons—in hippocampus”
Quote in the paperSubstantial claim - Findingown data
There is an apparent increase in NeuN+ cells in the secondary visual cortex (VCS) of AD-BXD77 F1 cases: cases average 363,000 ± 8200 cells versus 311,000 ± 9500 in controls (P = .006).
“Cases have an average population of 363,000 ± 8200 (s.e.) cells versus 311,000 ± 9500 (s.e.) in controls (P = .006).”
Quote in the paperNot a substantial claim - Findingown data
The 5×FAD transgene causes a general decrease in white matter volumes.
“While the transgene causes a general decrease in white matter volumes”
Quote in the paperSubstantial claim - Findingown data
Levene's F test confirmed significant heterogeneity of variance between groups of mice (F(3,53) = 2.8, P < 0.05).
“Levene's F test35 confirmed significant heterogeneity of variance between groups of mice (F(3,53) = 2.8, P < 0.05, Supplementary Data Table 8c).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Levene, H. in Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling (eds Orkin, I. & Hotelling, H.) 278–292 (Stanford University Press, 1960).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
Volumes of 11 of 13 telencephalic ROIs are larger in AD-BXD77 F1 cases, with LSN and cst excepted.
“volumes of 11 of 13 telencephalic ROIs are larger, the LSN and cst excepted”
Quote in the paperSubstantial claim - Findingown data
No significant transgene-by-genetic background interaction effects survive corrections of multiple tests.
“There are no significant transgene-by-genetic background interaction effects that survive corrections of multiple tests.”
Quote in the paperSubstantial claim - Findingown data
Fractional anisotropy signal is lower for 18 of 22 ROIs in 5×FAD cases than in controls.
“FA signal is lower for 18 of 22 of ROI in cases than in controls”
Quote in the paperSubstantial claim - Findingown data
For CA3, the loss of NeuN-positive cell numbers is associated with a two-tailed nominal t-test P of 0.08.
“For CA3 the loss is associated with a two-tailed nominal t-test P of 0.08 (Supplementary Table 9a).”
Quote in the paperNot a substantial claim - Findingown data
Changes in the volume of corticofugal projections mainly from layer 5 pyramidal neurons are among the most significant reductions detected between 5×FAD cases and controls, with loss of up to 8.1% in AD-BXD77 F1.
“Changes in the volume of the corticofugal projections mainly from layer 5 pyramidal neurons are among the most significant reductions that we detect between cases and controls with the loss of up to 8.1% in AD-BXD77 F1”
Quote in the paperSubstantial claim - Findingown data
The most enlarged ROIs in 5×FAD cases include the accessory olfactory nucleus, piriform cortex, anterior cingulate cortex, amygdala complex, visual cortex, and hippocampal formation.
“The most enlarged ROIs include the accessory olfactory nucleus, piriform cortex, anterior cingulate cortex, amygdala complex, visual cortex, and hippocampal formation”
Quote in the paperSubstantial claim - Findingown data
A total of 137 ROIs have significant changes in volume as a percentage of total brain volume at FDR <0.05 using Benjamini and Hochberg correction.
“A total of 137 ROIs have significant changes in their volume as a percentage of total brain volume at an FDR <0.05 using a Benjamini and Hochberg34 correction”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995). source
- Findingown data
There is evidence of neuron loss in smaller thalamic, mesencephalic, and hindbrain structures that have not been well studied in mouse models of AD or in human AD patients.
“We also have evidence of neuron loss in smaller thalamic, mesencephalic, and hindbrain structures that have not been well studied in mouse models of AD or in human AD patients.”
Quote in the paperSubstantial claim - Findingown data
In both 5×FAD cases and controls, the medial preoptic area (MPO), bed nucleus of the stria terminalis (BST), and lateral hypothalamic area (LHY) have the most significant sex differences, all with values greater than −logP of 4.0.
“As expected, in both groups, the medial preoptic area (MPO), the bed nucleus of the stria terminalis (BST), and the lateral hypothalamic area (LHY) have the most significant sex differences—all with values greater than −logP of 4.0”
Quote in the paperNot a substantial claim - Findingown data
There is a positive correlation of 0.49 between volume of the dorsal thalamus (THA) and better contextual fear memory (CFM) performance.
“and in Fig. 7f, a positive correlation of 0.49 between volume of the dorsal thalamus (THA) and better CFM performance.”
Quote in the paperSubstantial claim - Findingown data
There is a corresponding loss of NeuN-positive cell numbers in both CA1 and CA3.
“In both ROIs there is a corresponding loss of NeuN-positive cell numbers (Fig. 6k).”
Quote in the paperSubstantial claim - Findingown data
There is a strong rostral-to-caudal gradient in the impact of 5×FAD on ROI volumes that is shared by all AD-BXD F1 types.
“There is a strong rostral-to-caudal gradient in the impact of 5×FAD on volumes of ROIs that is shared by all AD-BXD F1 types (Fig. 4a).”
Quote in the paperSubstantial claim - Findingown data
The average coefficient of variation of independently segmented right and left ROIs is 1.8%.
“The average CV of these left-right comparisons is 1.8% (Fig. 3c).”
Quote in the paperSubstantial claim - Findingown data
All 22 fully delineated ROIs have higher levels of Aβ aggregate in AD-BXD77 F1 cases than in controls.
“All of these regions have higher levels of Aβ aggregate in the AD-BXD77 F1 cases than in controls”
Quote in the paperSubstantial claim - Findingown data
Only four fiber tracts reach significance with multiple-test correction: corticospinal tract (cst), fimbria (fim), post-commissural fornix (fop), and hypothalamic component of medial forebrain bundle (mbh).
“only four tracts reach significance with the multiple tests correction—the corticospinal tract (cst), the fimbria (fim), and post-commissural fornix (fop), and the hypothalamic component of medial forebrain bundle (mbh).”
Quote in the paperNot a substantial claim - Findingown data
In eight of nine nuclear ROIs that have smaller volumes in AD-BXD77 F1 cases, there is a significant reduction in NeuN+ numbers using Fisher's combined P test (P = 0.05).
“In eight of nine nuclear ROIs that have smaller volumes in Fig. 6h (SUT through POT) there is a significant reduction in NeuN+ numbers using Fisher’s combined P test (P of 0.05).”
Quote in the paperSubstantial claim - Findingown data
The visual cortex (VCX) has among the highest differences in correlations between cases and controls for both CFA and CFM.
“Remarkably, the visual cortex (VCX) has among the highest differences in correlations between cases and controls for both CFA and CFM (Fig. 7e).”
Quote in the paperNot a substantial claim - Findingown data
Only three ROIs have correlation differences for CFM between cases and controls: medial septal nucleus (MSN, ρ +0.40 for cases vs −0.29 for controls), visual cortex (VCX, ρ −0.41 cases vs +0.18 for controls), and ventromedial hypothalamic nucleus (VMH, ρ +0.11 for cases vs −0.45 for controls).
“In contrast, we detected only three ROIs with correlation differences for CFM between cases and controls: the medial septal nucleus (MSN, ρ of +0.40 for cases vs −0.29 for controls), the visual cortex (VCX, ρ −0.41 cases vs +0.18 for controls, Fig. 7e), and the ventromedial hypothalamic nucleus (VMH, ρ +0.11 for cases vs −0.45 for controls).”
Quote in the paperNot a substantial claim - Findingown data
There are significant correlations between volumes of ROIs and behavioral data.
“There are significant correlations between volumes of ROIs and behavioral data (Fig. 7).”
Quote in the paperSubstantial claim - Findingown data
The subset of nine thalamic and brainstem regions have a modest negative correlation of Aβ levels with volumes (ρ = 0.32 ± 0.14).
“In contrast, the subset of nine thalamic and brainstem regions, do have a modest negative correlation of Aβ levels with volumes (ρ = 0.32 ± 0.14, Supplementary Table 9d).”
Quote in the paperNot a substantial claim - Findingown data
The dorsal lateral geniculate nucleus (LGD) is the only thalamic ROI that is significantly enlarged by 5×FAD transgene expression.
“For example, the dorsal lateral geniculate nucleus (LGD) is the only thalamic ROI that is significantly enlarged by 5×FAD transgene expression (Fig. 4a,b).”
Quote in the paperNot a substantial claim - Findingown data
Volumes of 29 ROIs correlate with fear acquisition.
“Volumes of 29 ROIs correlate with fear acquisition—a key learning metric.”
Quote in the paperSubstantial claim - Findingown data
The lateral posterior nucleus (LPT) is significantly reduced in volume.
“Its immediate neighbor, the lateral posterior nucleus (LPT), homolog of the human pulvinar, is significantly reduced in volume (Fig. 4a,b).”
Quote in the paperSubstantial claim - Findingreasoning
We estimate 10 to 25% loss of pyramidal neurons in AD-BXD77F1 cases by 14 months.
“We estimate 10 to 25% loss of pyramidal neurons in AD-BXD77F1 cases by 14 months.”
Quote in the paperSubstantial claim - Findingcitation
The correlations between variation in CFM and volume highlight the dorsal thalamus (THA) and three of its components (LAT, TPA, DGT), three amygdalar regions (BLA, LAA, PAN), the hilus of dentate gyrus (DGH), and derivatives of the cortical subplate (CTS) such as the claustrum.
“With respect to memory, the correlations between variation in CFM and volume highlight the dorsal thalamus (THA) and three of its components (LAT, TPA, DGT), but also three amygdalar regions (BLA, LAA, PAN), the hilus of dentate gyrus (DGH), and derivatives of the cortical subplate (CTS) such as the claustrum58.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Bruguier, H. et al. In search of common developmental and evolutionary origin of the claustrum and subplate. J. Comp. Neurol. 528, 2956–2977 (2020). source
- Findingown data
Of 22 ROIs studied in detail, the volumes of 12 telencephalic ROIs do not covary with Aβ levels across the AD-BXD77 F1 5×FAD cases (ρ = 0.00).
“Of 22 ROIs studied in detail, the volumes of 12 telencephalic ROIs do not covary with Aβ levels across the AD-BXD77 F1 5×FAD cases (ρ = 0.00).”
Quote in the paperSubstantial claim - Findingown data
In our work, two thalamic ROIs with significant volumetric loss also lose neurons-the perifascicular nucleus (PFT) and the anterior ventral nucleus (AVT).
“In our work, two thalamic ROIs with significant volumetric loss also lose neurons—the perifascicular nucleus (PFT) and the anterior ventral nucleus (AVT) (Fig. 4a, Fig. 6h-l), and both have roles in cognition and memory67.”
Quote in the paperNot a substantial claim - Findingown data
Fractional anisotropy decreased in eight ROIs in the 5×FAD cases compared to controls by 10 to 17%.
“3D images highlighting eight ROIs in which fractional anisotropy decreased in the 5×FAD cases compared to controls by 10 to 17% compared to controls.”
Quote in the paperSubstantial claim- Rests on an assumption: The DMBA coordinate space is a consensus for the C57BL/6J strain at stereotaxic precision.
- Findingown data
Volume changes of ROIs caused by the 5×FAD transgene range from 10% increases to 10% decreases.
“Volume changes range from 10% increases (more intense reds) to 10% decreases (more intense blues).”
Quote in the paperSubstantial claim- Rests on an assumption: The DMBA coordinate space is a consensus for the C57BL/6J strain at stereotaxic precision.
- Interpretationown data
Approximately 20% of pyramidal neurons have died in CA3 of AD-BXD77 F1 cases by 14 months of age.
“we estimate that by 14 months of age approximately 20% of pyramidal neurons have died in CA3 of AD-BXD77 F1 cases.”
Quote in the paperSubstantial claim - Interpretationown data
The authors regard the correlation results as proof-of-concept that they can detect correlations between variation in ROI volumes and specific behaviors known to be diagnostic features of human AD.
“Rather than making claims about any specific correlation we regard them as proof-of-concept that we are now able detect correlations between variation in ROI volumes, and potentially with variation in neuron densities and numbers, and specific behaviors known to be diagnostic features of human AD.”
Quote in the paperSubstantial claim- Rests on an assumption: The 5×FAD transgene in mice models the structural and behavioral effects of Alzheimer's disease.
- Interpretationown data
The study provides the first comprehensive volumetric atlas of the impact of the 5×FAD set of human Alzheimer's disease gene variants on 231 well-defined CNS regions in mice, including structures as small as the perifascicular nucleus (0.2 mm3).
“We provide the first comprehensive volumetric atlas of the impact of the 5×FAD set of human Alzheimer’s disease gene variants on 231 well-defined CNS regions in mice, including structures as small as the perifascicular nucleus (0.2 mm3).”
Quote in the paperSubstantial claim- Rests on an assumption: There is not much systematic case-control data on structural effects of Alzheimer's disease in either humans or mice, particularly on the integrity of subcortical regions as a function of AD mutation type, sex, age of onset of behavioral symptoms, environment, or treatment history.
- Rests on an assumption: The 5×FAD transgene in mice models the structural and behavioral effects of Alzheimer's disease.
- Interpretationown data
The larger numbers of regions and tracts defined with low coefficients of variation explain positive results.
“and 3. the larger numbers of regions and tracts defined with low coefficients of variation (Fig. 3c).”
Quote in the paperSubstantial claim - Interpretationreasoning
Patterns and gradients of differential vulnerability to the 5×FAD are likely to be mediated by regional heterogeneity in gene and protein expression and by differences in circuitry and activity.
“Patterns and gradients of differential vulnerability to the 5×FAD are likely to be mediated by regional heterogeneity in gene and protein expression and by differences in circuitry and activity.”
Quote in the paperNot a substantial claim - Interpretationown data
The global gradient in volumetric changes has been missed in lower-resolution MRI of 5×FAD mice.
“This global gradient in volumetric changes has been missed in lower-resolution MRI of 5×FAD mice.”
Quote in the paperSubstantial claim - Interpretationown data
In our case, the increase in volumes in the hippocampus is evidently linked to loss of neurons.
“In our case, the increase in volumes in the hippocampus are evidently linked to loss of neurons.”
Quote in the paperSubstantial claim - Interpretationreasoning
Higher resolution of ex vivo DTI is a technical explanation for the positive results.
“But three technical explanations for our positive results may be more important: 1. the higher resolution of ex vivo DTI (Fig. 2a);”
Quote in the paperSubstantial claim - Interpretationcitation
The temporal dynamics of the 5×FAD mouse is a reasonable match to prodromal autosomal dominant forms of AD in humans.
“In defense of this strategy, the expression of Aβ42 plaques in humans with highly penetrant APP and PSEN mutations occurs as much as 10–20 years before serious cognitive loss75,76, so in this regard the temporal dynamics of the 5×FAD mouse is actually a reasonable match to prodromal autosomal dominant forms of AD in humans.”
Quote in the paperSubstantial claim - Interpretationown data
Our methods now have sufficient throughput that it is practical to achieve sample sizes adequate to link changes in ROI volumes to cognitive function.
“Our methods now also have sufficient throughput that it is practical to achieve samples size that are adequate to link changes in ROI volumes to cognitive function (Fig. 7).”
Quote in the paperSubstantial claim - Interpretationnone given
The smaller size of the mouse brain demands much higher absolute spatial resolution to achieve the same or even better ROI delineations.
“But the smaller size of the mouse brain does demand much higher absolute spatial resolution to achieve the same or even better ROI delineations.”
Quote in the paperSubstantial claim - Interpretationreasoning
The later stages of human AD are not modeled well by this or most other AD models.
“In contrast, the later stages of human AD are not modeled well by this or most other AD models.”
Quote in the paperSubstantial claim - Study design and conductown data
Significant heterogeneity of variance across groups was confirmed using Levene's F statistic (F(3,53) = 2.8, P < 0.05).
“We tested for homogeneity of variance using Levene’s F statistic35 and confirmed significant heterogeneity of variance (F(3,53) = 2.8, P < 0.05).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Levene, H. in Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling (eds Orkin, I. & Hotelling, H.) 278–292 (Stanford University Press, 1960).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductown data
All ROIs can be delineated repeatedly in both cases and controls with low coefficients of variation.
“The DMBA ontology has fewer terminal leaves (children) than the full CCFv3 but we have validated that all can be delineated repeatedly in both cases and controls with low coefficients of variation as described below.”
Quote in the paperSubstantial claim - Interpretationreasoning
This study's single most important technical contribution is to show that we can achieve the resolution needed to diagnostically dissect and analyze hundreds of ROIs, down to some of the smallest brainstem nuclei.
“This is perhaps the single most important technical contribution of our work—to show that we can achieve the resolution needed to diagnostically dissect and analyze hundreds of ROIs, down to some of the smallest brainstem nuclei.”
Quote in the paperSubstantial claim - Study design and conductreasoning
None of these differences reach significance with correction for multiple tests.
“But given the relatively modest sample size in the two subgroups and the large number of tests, none of these differences reach significance with correction for multiple tests.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 30
- May combine two claims. 57
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationAs in human families with PSEN1 mutations, the effects may be restricted to the prodromal phase and be followed by serious volume reduction and neuron death.
“As in human families with PSEN1 mutations, this may be restricted to the prodromal phase and be followed by serious volume reduction and neuron death57.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [57] Keifer, O. P. Jr., Hurt, R. C., Ressler, K. J. & Marvar, P. J. The physiology of fear: reconceptualizing the role of the central amygdala in fear learning. Physiology 30, 389–401 (2015). source
The available passages from the paper’s Abstract discuss fear learning, amygdala circuits, and genetic variants associated with fear and PTSD. Searches for PSEN1 mutations, a prodromal phase, volume reduction, and neuronal death found no passage addressing the attributed claim. (LLM, conf=0.75)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMost studies have used only the C57BL/6J strain, which is known to be relatively resistant to the transgene effects.
“One source of differences may be that most studies have used only the C57BL/6J strain10, known to be relatively resistant to the transgenes effects.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [10] Neuner, S. M., Heuer, S. E., Huentelman, M. J., O’Connell, K. M. S. & Kaczorowski, C. C. Harnessing genetic complexity to enhance translatability of Alzheimer’s disease mouse models: a path toward precision medicine. Neuron 101, 399–411 (2019). source
The Discussion (‘Improving rigor and reproducibility in preclinical studies’; page unavailable) says traditional studies use a single inbred strain, but does not establish that most use C57BL/6J specifically. The Discussion (‘The role of modifier genes in normal aging and resilience to AD’; page unavailable) says the B6 background appears to attenuate the cognitive effects of 5XFAD mutations, supporting the resistance point for those effects rather than transgene effects generally. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMutations in both APP and PSEN1 cause aberrant APP cleavage and clearance that lead to neuroinflammation, activation of astrocytes and microglia, and changes in bioenergetics.
“Mutations in both APP and PSEN1 cause aberrant APP cleavage and clearance4,47 that lead to neuroinflammation, the activation of astrocytes and microglia, and changes in bioenergetics44,48.”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [4] Ringman, J. M. et al. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr. Neurol. Neurosci. Rep. 14, 499 (2014). source
The 'Amyloid Precursor Protein' and 'The Presenilins' sections (pages not supplied) describe how APP and PSEN1 mutations alter APP cleavage and Aβ production. The 'Autosomal dominant forms of AD' section distinguishes reduced Aβ clearance in late-onset AD from increased Aβ synthesis in PSEN1 mutation carriers; it does not establish aberrant clearance for both mutations. The later inflammation, glial-activation, and bioenergetics claims carry separate citations. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [47] Macdonald, I. R. et al. Early detection of cerebral glucose uptake changes in the 5×FAD mouse. Curr. Alzheimer Res. 11, 450–460 (2014). source
The Introduction (page not provided) describes familial-AD mutation mouse models with activated microglia, neuroinflammation, mitochondrial abnormalities, and possible changes in glucose metabolism. It does not mention astrocyte activation, and it presents the metabolic link as a possibility rather than an established consequence. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [44] Andersen, J. V. et al. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5×FAD mouse model of Alzheimer’s disease. Cell Death Dis. 12, 954 (2021). source
The Introduction (page unavailable) links Aβ accumulation to astrocyte changes and early metabolic changes in Alzheimer’s disease. The Discussion (page unavailable) reports altered astrocyte metabolism in 5xFAD mice, but does not establish the claimed chain from aberrant APP cleavage and clearance to neuroinflammation and microglial activation. The cleavage-and-clearance portion also has separate citations in the citing sentence. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [48] Shin, L. M. & Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169–191 (2010). source
May combine two claims.
InterpretationcitationThe use of sophisticated multiangle methods enhances contrast and precision of delineations, explaining positive results.
“2. the use of sophisticated multiangle methods that enhance contrast and precision of delineations31;”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [31] Mansour, H. et al. The Duke Mouse Brain Atlas: MRI and light sheet microscopy stereotaxic atlas of the mouse brain. Sci. Adv. 11, eadq8089 (2025). source
The Results sections on diffusion tensor data and the average MRH atlas report that more angular samples help resolve crossing fibers and that multiple MRI contrasts improve recognition of cytoarchitectural boundaries. Figure 2 also attributes improved image contrast and clearer borders to precision registration and averaging. The paper does not attribute both improved contrast and more precise delineation to a single multiangle method. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
InterpretationcitationPolarities of effects are linked to differences in metabolic rates.
“One plausible idea is that polarities of effects are linked to differences in metabolic rates49-51.”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [49] Evangelio, M., García-Amado, M. & Clascá, F. Thalamocortical projection neuron and interneuron numbers in the visual thalamic nuclei of the adult C57BL/6 mouse. Front. Neuroanat. 12, 27 (2018). source
The Introduction discusses differences in neuron numbers between mouse strains, and the Discussion describes differences in labeling among visual thalamic nuclei; neither links the polarity of effects to metabolic rates. Searches for the quoted phrase and for metabolic rates or metabolism found no passage in our copy addressing that proposed link. No page numbers were provided for these passages. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [50] Eimer, W. A. & Vassar, R. Neuron loss in the 5×FAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Mol. Neurodegener. 8, 2 (2013). source
The Results and Discussion passages address neuron loss, Aβ42 accumulation, and Caspase-3 activation in 5XFAD mice, not polarities of effects or metabolic rates. Searches for the quoted phrase and for metabolic-rate differences found no passage addressing the proposed link; page numbers were not available in our copy. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [51] Busser, J., Geldmacher, D. S. & Herrup, K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J. Neurosci. 18, 2801–2807 (1998). source
The Discussion compares how quickly neurons die during development and in Alzheimer’s disease, but does not link that difference to metabolic rates. Searches for metabolic rates and related terms found no passage addressing the proposed explanation for polarities of effects. The indexed passages provide no page numbers. (LLM, conf=0.73)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOur findings align with the work of Gurdon and colleagues who detected decreased NeuN label in the hippocampus.
“Our findings align with the work of Gurdon and colleagues8 who detected decreased NeuN label in the hippocampus.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [8] Gurdon, B. et al. Detecting the effect of genetic diversity on brain composition in an Alzheimer’s disease mouse model. Commun. Biol. 7, 605 (2024). source
May combine two claims.
PremisecitationThese ROIs have been previously associated with fear memory and align with work at the circuit level.
“These ROIs have been previously associated with fear memory56,59-66 and align with work at the circuit level62.”
Quote in the paperNot a substantial claim7 of 9 sources checked- cites [56] Antoniadis, E. A. & McDonald, R. J. Amygdala, hippocampus and discriminative fear conditioning to context. Behav. Brain Res. 108, 1–19 (2000). source
- cites [59] Venkataraman, A. & Dias, B. G. Expanding the canon: an inclusive neurobiology of thalamic and subthalamic fear circuits. Neuropharmacology 226, 109380 (2023). source
- cites [60] Frontera, J. L. et al. The cerebellum regulates fear extinction through thalamo–prefrontal cortex interactions in male mice. Nat. Commun. 14, 1508 (2023). source
- cites [61] Penzo, M. A. et al. The paraventricular thalamus controls a central amygdala fear circuit. Nature 519, 455–459 (2015). source
- cites [62] Ratigan, H. C., Krishnan, S., Smith, S. & Sheffield, M. E. J. A thalamic–hippocampal CA1 signal for contextual fear memory suppression, extinction, and discrimination. Nat. Commun. 14, 6758 (2023). source
- cites [63] Sun, Y., Gooch, H. & Sah, P. Fear conditioning and the basolateral amygdala. F1000Res https://doi.org/10.12688/f1000research.21201.1 (2020). source
- cites [64] Bernier, B. E. et al. Dentate gyrus contributes to retrieval as well as encoding: evidence from context fear conditioning, recall, and extinction. J. Neurosci. 37, 6359–6371 (2017). source
- cites [65] Zhang, Y., Wang, Z., Ju, J., Liao, J. & Zhou, Q. Elevated activity in the dorsal dentate gyrus reduces expression of fear memory after fear extinction training. J. Psychiatry Neurosci. 46, E390–E401 (2021). source
- cites [66] Hernández-Rabaza, V. et al. The hippocampal dentate gyrus is essential for generating contextual memories of fear and drug-induced reward. Neurobiol. Learn. Mem. 90, 553–559 (2008). source
May combine two claims.
PremisecitationCortex and hippocampus have higher glucose utilization than globus pallidus, as do the three exceptional nuclei in thalamus, hypothalamus, and midbrain that all increase in volume-the LGD, SCH, and ICC.
“For example, cortex and hippocampus have higher glucose utilization than globus pallidus, as do the three exceptional nuclei in thalamus, hypothalamus, and midbrain that all increase in volume—the LGD, SCH, and ICC (Fig. 4a,b)49,50.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [49] Evangelio, M., García-Amado, M. & Clascá, F. Thalamocortical projection neuron and interneuron numbers in the visual thalamic nuclei of the adult C57BL/6 mouse. Front. Neuroanat. 12, 27 (2018). source
The Results section on dLGN and LP volume reports measurements and a left–right difference in dLGN volume, not an increase in volume across the three named nuclei. Searches for glucose utilization, globus pallidus, SCH, and ICC found no passage addressing the claimed comparisons. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [50] Eimer, W. A. & Vassar, R. Neuron loss in the 5×FAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Mol. Neurodegener. 8, 2 (2013). source
The Results section discusses neuron loss and Caspase-3 activation in the 5XFAD cortex and subiculum, not regional glucose utilization or volume increases. Searches for glucose utilization, globus pallidus, and the LGD, SCH, and ICC found no passage addressing the claimed comparisons. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBoth LGD and LPT are crucial components of the visual system and have dense reciprocal connections with visual cortex, but have radically different physiology and functions, and only the LGD has high numbers of GABAergic interneurons.
“Both nuclei are crucial components of the visual system and have dense reciprocal connections with visual cortex, but these nuclei have radically different physiology and functions, and only the LGD has high numbers of GABAergic interneurons52.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [52] Park, C. et al. Stress granules contain RBFOX2 with cell cycle-related mRNAs. Sci. Rep. 7, 11211 (2017). source
The Introduction and Discussion passages concern Rbfox proteins and stress granules, not the visual nuclei described in the claim. Searches for LGD, LPT, reciprocal visual-cortex connections, and GABAergic interneurons found no passage addressing those points. No page numbers were available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious work has reported covariation of the loss of cortical layer 5 neurons in 5×FAD mice with levels of Aβ42 deposition.
“Previous work has reported covariation of the loss of cortical layer 5 neurons in 5×FAD mice with levels of Aβ42 deposition53.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [53] Kim, K. K., Adelstein, R. S. & Kawamoto, S. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J. Biol. Chem. 284, 31052–31061 (2009). source
The NeuN/Fox-3 identification section describes neuronal staining, and the cross-reactivity section examines anti-NeuN staining; neither addresses neuron loss in 5×FAD mice. Searches for cortical layer 5 neuron loss, 5×FAD, and Aβ42 deposition found no passage reporting the claimed covariation. Page numbers are unavailable in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
Study design and conductcitationA pipeline built on ANTs registered the 66 volumes into a common space to correct for small displacements caused by eddy currents in the magnet.
“Once scans were completed, a pipeline built on ANTs90 registered the 66 volumes into a common space to correct for small displacements caused by eddy currents in the magnet, which vary between volumes.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [90] St-Jean, S., Coupé, P. & Descoteaux, M. Non Local Spatial and Angular Matching: enabling higher spatial resolution diffusion MRI datasets through adaptive denoising. Med. Image Anal. 32, 115–130 (2016). source
Section 3.4 (p. 10) says ANTs was used to register white-matter masks to in-vivo datasets, not to register 66 scan volumes into a common space. Section 5.7 (p. 24) discusses eddy-current correction as a preprocessing step but does not say the ANTs registration performed it. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe contextual fear conditioning protocol used matches that previously used in the AD-BXD F1s.
“The protocol used matches that previously used in the AD-BXD F1s10 83.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [10] Neuner, S. M., Heuer, S. E., Huentelman, M. J., O’Connell, K. M. S. & Kaczorowski, C. C. Harnessing genetic complexity to enhance translatability of Alzheimer’s disease mouse models: a path toward precision medicine. Neuron 101, 399–411 (2019). source
- cites [83] Sasani, T. A. et al. A natural mutator allele shapes mutation spectrum variation in mice. Nature 605, 497–502 (2022). source
The Methods section on construction of BXD lines describes breeding, and the Methods section on whole-genome sequencing describes tissue collection and genetic analysis. Neither describes contextual fear conditioning or compares its protocol with one used in AD-BXD F1s (searched: “contextual fear conditioning AD-BXD F1s” and “fear conditioning protocol behavioral testing Alzheimer BXD F1”). (LLM, conf=0.75)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationDelineations of the dorsal lateral geniculate nucleus (LGD) of AD-BXD F1s have mean unilateral volumes of approximately 0.35 ± 0.04 SD mm3, whereas previous estimates of adult B6D2F1 hybrid from celloidin-sectioned Nissl-stained material are 0.32 ± 0.03 mm3 with correction for shrinkage.
“For example, delineations of the dorsal lateral geniculate nucleus (LGD) of AD-BXD F1s have mean unilateral volumes of approximately 0.35 ± 0.04 SD mm3, whereas our previous estimates of adult B6D2F1 hybrid from celloidin-sectioned Nissl-stained material are 0.32 ± 0.03 mm3 with correction for shrinkage94.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [94] Seecharan, D. J., Kulkarni, A. L., Lu, L., Rosen, G. D. & Williams, R. W. Genetic control of interconnected neuronal populations in the mouse primary visual system. J. Neurosci. 23, 11178–11188 (2003). source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataEleven ROIs have nominally significant correlations with both behaviors, including key sensory regions (VCP, VCS, and MGD) linked to early symptoms of AD in humans.
“Eleven ROIs have nominally significant correlations with both behaviors (Supplementary Table 10), including key sensory regions (VCP, VCS, and MGD) linked to early symptoms of AD in humans71-74.”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [71] Hong, S., Baek, S. H., Lai, M. K. P., Arumugam, T. V. & Jo, D. G. Aging-associated sensory decline and Alzheimer’s disease. Mol. Neurodegener. 19, 93 (2024). source
The Background describes visual and auditory processing deficits at early stages of AD, and the Visual impairment section links visual-cortex pathology to AD-related visual disruption. The Auditory system section identifies the medial geniculate nucleus as an auditory pathway region, but our copy does not establish that VCP, VCS, and MGD individually are linked to early AD symptoms in humans. The eleven ROI correlations are attributed to the citing paper’s Supplementary Table 10, not to this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [72] Murphy, C. Olfactory and other sensory impairments in Alzheimer disease. Nat. Rev. Neurol. 15, 11–24 (2019). source
- cites [73] Zhang, N. K., Zhang, S. K., Zhang, L. I., Tao, H. W. & Zhang, G. W. Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease. Front. Aging Neurosci. 15, 1213379 (2023). source
The Introduction (page unavailable) says visual and auditory deficits can appear before cognitive decline in people with AD, and “Pathological changes in visual cortex” describes early changes in visual association areas. The paper does not establish the claimed link for each named region, particularly MGD. The eleven ROI correlations are attributed to the citing paper’s Supplementary Table 10, not to this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [74] Albers, M. W. et al. At the interface of sensory and motor dysfunctions and Alzheimer’s disease. Alzheimers Dement. 11, 70–98 (2015). source
The Visual System neuropathology section reports that visual cortical areas can be affected early in AD, supporting the visual-region portion. The Auditory System neuropathology section reports pathology in the medial geniculate nucleus but says its presence in presymptomatic patients with hearing loss has not been investigated, so it does not establish that region’s link to early human symptoms. The eleven-ROI correlations are the citing paper’s own result, not a finding attributed to this source. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPFT and AVT both have roles in cognition and memory.
“and both have roles in cognition and memory67.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [67] Aggleton, J. P., Pralus, A., Nelson, A. J. & Hornberger, M. Thalamic pathology and memory loss in early Alzheimer’s disease: moving the focus from the medial temporal lobe to Papez circuit. Brain 139, 1877–1890 (2016). source
The Introduction (page unavailable) links the anterior thalamic nuclei to cognition and episodic memory, and Clinical and therapeutic implications (page unavailable) describes roles in attention and learning. Our copy does not identify PFT or AVT by those abbreviations or establish the claim separately for both, so the specific two-structure attribution is not fully supported. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAll five parental strains have been deeply sequenced and all F1 hybrids therefore have completely defined genomes.
“All five of the parental strains have been deeply sequenced and all F1 hybrids therefore have completely defined genomes11,82.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [11] Ashbrook, D. G. et al. A platform for experimental precision medicine: the extended BXD mouse family. Cell Syst. 12, 235–247 (2021). source
The Introduction reports full sequence data for both BXD parents, not five parental strains. The Discussion (Future Directions) says that isogenic BXD F1 lines have entirely defined genomes, supporting the genome claim for those hybrids but not the stated five-parent basis. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [82] Oakley, H. et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129–10140 (2006). source
Materials and Methods says the engineered APP and PS1 transgenes were sequenced and describes breeding with B6/SJL F1 hybrids. Neither that passage nor the transgenic-strategy section addresses deep sequencing of five parental strains or whether the F1 hybrids have completely defined genomes. Searched for parental-strain sequencing and F1 genome definition. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationROI delineation involved cycles of interactions between automated protocols and appraisal by skilled neuroanatomists following the strategy applied to human high throughput neuroimaging.
“In brief, this has involved cycles of interactions between automated protocols described above and an appraisal by skilled neuroanatomists following the strategy applied to human high throughput neuroimaging95.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [95] Park, Y.-G. et al. Protection of tissue physicochemical properties using polyfunctional crosslinkers. Nat. Biotech. 37, 73–83 (2018). source
The Materials and Methods sections describe automatic atlas alignment and human-reviewed, semi-automatic axon tracing, but not the claimed strategy for ROI delineation in human high-throughput neuroimaging. Searches for skilled neuroanatomist appraisal and iterative automated ROI delineation found no passage addressing that strategy. (LLM, conf=0.73)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThalamic regions atrophy even in presymptomatic human carriers of PSEN1 mutations.
“Thalamic regions atrophy even in presymptomatic human carriers of PSEN1 mutations70.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [70] Ryan, N. S. et al. Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease. Brain 136, 1399–1414 (2013). source
May combine two claims.
Study design and conductcitationThe numerical analyses are relatively robust, and in both cases and controls the counts align reasonably well with well validated estimates of neuron numbers.
“Nonetheless, the numerical analyses are relatively robust, and in both cases and controls our counts align reasonably well with well validated estimates of neuron numbers23.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [23] Tian, Y., Johnson, G. A., Williams, R. W. & White, L. A rapid workflow for neuron counting in combined light sheet microscopy and magnetic resonance histology. Front. Neurosci. 17, 1223226 (2023). source
The Abstract (page unavailable) says the paper’s mouse neuronal-density estimates fall within the range of previous stereological studies. The Discussion (page unavailable) says most cortical-region densities were consistent with earlier reports, but identifies several regions with higher estimates. The paper does not establish that the citing authors’ counts align with validated neuron-number estimates in both cases and controls; its comparison is primarily of density in mice. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataWelch's t-tests did not detect any difference between male and female controls (P = 0.32), nor between all cases and all controls (P = 0.62).
“Welch’s t-tests did not detect any difference between male and female controls (P = 0.32), but surprisingly, there were also no differences between all cases and all controls (P = 0.62, combined sexes).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWhen F1s have a BXD77 sire, 124 of the 137 regions have significant 5×FAD effects at nominal P <0.05; corresponding numbers for BXD101, BXD32, and BXD65 sires are 41, 27, and 26.
“When F1s have a BXD77 sire, 124 of the 137 regions have significant 5×FAD effects at a nominal P <0 .05 (see green ROI tags in Fig. 4c). Corresponding numbers for BXD101, BXD32, and BXD65 sires are 41, 27, and 26.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe transgene effects trend in precisely the same direction on all four genetic backgrounds; only the hypoglossal nucleus (HGN) is an exception.
“Of more biological importance, the transgene effects trend in precisely the same direction on all four genetic backgrounds (Fig. 4c, the four blue and pink columns labeled %). Only the hypoglossal nucleus (HGN) is an exception.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt a fine-grained level, 31 ROIs have significant differences even with a stringent Bonferroni correction, mainly on the BXD77 background.
“At this fine-grained level 31 ROIs have significant differences even with a stringent Bonferroni correction, but mainly on the BXD77 background”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEffects of the 5×FAD transgene are more visually striking in females than males, whether the polarity is an increase or a decrease in volume, indicating higher female variance.
“Effects of the transgene are more visually striking in females than males, and this is true whether the polarities are an increase or a decrease in volume (Fig. 4d)—a sign of higher female variance (Fig. 4d).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth sex-stratified tests were highly significant: female cases had increased variance (P = 0.0025) and male cases had more consistent responses and reduced variance (P = 0.0046).
“However, both sex-stratified tests were highly significant: female cases with increased variance (P = 0.0025); male cases with more consistent responses and reduced variance (P = 0.0046).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSeveral ROIs have strong sex differences only in cases or only in controls; for example, subthalamus (SUT) in cases, and striatum-like amygdalar nuclei (SLA) and medial forebrain bundle (mbh) in controls.
“Several ROIs have strong sex differences only in cases or only in controls. For example, the subthalamus (SUT) has a strong sex difference in cases (−logP of 4.2), while the striatum-like amygdalar nuclei (SLA) and the medial forebrain bundle (mbh) have strong differences only in controls.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe reduction in NeuN-positive cell density is −18.2 ± 5.0% in CA1 and −24.5 ± 2.6% in CA3 relative to control.
“The reduction of terms of density amounts to −18.2 ± 5.0% in CA1 and −24.5 ± 2.6% in CA3 relative to control.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe nucleus accumbens gains volume in 5×FAD cases but the dorsal striatum does not.
“The nucleus accumbens gains volume but not the dorsal striatum.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAlmost all diencephalic, mesencephalic and hindbrain structures have smaller volumes in 5×FAD cases, as well as most fiber tracts.
“In contrast, almost all diencephalic, mesencephalic and hindbrain structures have smaller volumes, as well as most fiber tracts”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor contextual fear memory (CFM), 9 ROIs have significant correlations at PBH < 0.05 and 47 ROIs at PBH < 0.1.
“Corresponding numbers for CFM are 9 and 47 ROIs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSex accounts for approximately 7% of the variance in the overall model that includes all ROIs and 7% of variance of the 137 ROIs significantly affected by the transgene.
“Sex accounts for approximately 7% of the variance in the overall model that includes all ROIs and sex also accounts for 7% of variance of the 137 ROIs significantly affected by the transgene.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOf the 137 ROIs significantly affected by the transgene, 123 are significant in females and 93 are significant in males.
“Of these ROIs 123 are significant in females and 93 are significant in males (green bars in Fig. 4d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTotal ventricular volume is reduced in 5×FAD cases but the difference is insignificant.
“The total ventricular volume (Vnt) is reduced, but the difference is insignificant.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe polarity of volume effects is reversed for all thalamic and brainstem structures in AD-BXD77 F1 cases, and this is highly significant (Fisher combined P <0.0001).
“In contrast, the polarity of effects is reversed for all thalamic and brainstem structures (Fig. 6h) and are again highly significant (Fisher combined P of <0.0001).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTwenty-nine ROIs have significant correlations with contextual fear acquisition (CFA) at PBH < 0.05 and 56 ROIs at PBH < 0.1.
“Twenty-nine ROIs have significant correlations with CFA at a PBH < 0.05 and 56 ROIs at a PBH < 0.1”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe majority of telencephalic grey matter structures have larger volumes in 5×FAD cases; only the striatum (STR) and pallidum (PAL) are exceptions.
“The majority of telencephalic grey matter structures have larger volumes; only the striatum (STR) and pallidum (PAL) are exceptions.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe dorsal lateral geniculate nucleus (LGD) and inferior colliculus (ICC and ICO) are notable exceptions to the rostrocaudal gradient, with large volumes.
“Two other notable exceptions are the dorsal lateral geniculate nucleus (LGD) and the inferior colliculus (ICC and ICO)—both of which have large volumes”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGenetic background explains 23% of the variance in fractional volume of all ROIs and 20% of the variance of the 137 ROIs significantly altered by the transgene.
“The genetic background into which the transgene is placed—in our study defined by the strain of the BXD sire to which the C57BL/6J congenic dam is crossed—explains 23% of the variance in fractional volume of all ROIs, and 20% of that of the 137 ROIs with volumes significantly altered by the transgene when we test using a well-powered full model”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCorrelations of fear memory and volumes of hilus of the dentate gyrus (DGH) and posterior amygdala (PAN) are both strongly negative (ρ = −0.48 for DGH and −0.49 for PAN).
“Correlations of fear memory and volumes of hilus of the dentate gyrus (DGH) and the posterior amygdala (PAN) are both strongly negative (Fig. 7b,d). Three transgenic females have anomalously large volumes and poor memory retention, but even rank correlations are negative (ρ of −0.48 for DGH and −0.49 for PAN).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFourteen ROIs are nominally significant for sex-by-transgene interaction effects, including subthalamus (SUT, P = 0.0016), pontine central gray (PCG, P = 0.011), and hippocampus (HPO, P = 0.018); none survive multiple test correction.
“Fourteen ROIs are nominally significant including the subthalamus (SUT, P = 0.0016), the pontine central gray (PCG, P = 0.011), and the hippocampus (HPO, P = 0.018). While intriguing, none of these interactions stand up to a multiple test correction.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe CA1 reduction in NeuN-positive cell density is not significant (PBH = 0.39), but the CA3 reduction is significant (PBH = 0.04).
“In the case of CA1 this difference is not significant (PBH = 0.39) but is in the case of CA3 (PBH = 0.04).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe nine significant ROIs for CFM are TPA, THA, LAT, LAA, CTS, DGH, BLA, DGT, and PAN-a list enriched for thalamic, amygdalar, and hippocampal ROIs.
“In comparison, the nine significant ROIs for CFM are TPA, THA, LAT, LAA, CTS, DGH, BLA, DGT, and PAN—a list that is enriched for thalamic, amygdalar, and hippocampal ROIs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe link between increased hippocampal volume and neuron loss is most clearcut in CA3 but is also likely true of CA1.
“This is most clearcut in CA3 but is also likely to be true of CA1 (Fig. 6i,k).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFourteen of the 29 ROIs are thalamic nuclei (AVT, ILM, PCN, PFT, PIT, POT, SU, THA, TPA, TSM, VAL, VGT, VMT, and ZIN), as well as the lateral forebrain bundle (lbu); two others are tracts associated with the hippocampus (for and fim); one is the basomedial amygdala (BMA); and the remaining seven are motor-related nuclei and tracts (ION, MRN, MBM, PNM, PRT, RED, TMN, and cst).
“Fourteen of these are thalamic nuclei: the AVT, ILM, PCN, PFT, PIT, POT, SU, THA, TPA, TSM, VAL, VGT, VMT, and ZIN, as well as the lateral forebrain bundle (lbu). Two others are tracts associated with the hippocampus (for and fim); one is the basomedial amygdala (BMA); and the remaining seven are motor-related nuclei and tracts (ION, MRN, MBM, PNM, PRT, RED, TMN, and cst).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataForty-six ROIs with opposite polarities of correlations between cases and controls are nominally significant with fear acquisition, but none meet an FDR correction at PBH < 0.05.
“Although 46 ROIs with opposite polarities of correlations between cases and controls are nominally significant with fear acquisition (e.g., Fig. 7c,e), none meet an FDR corrections at PBH < 0.05.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe only midbrain structure that expands significantly is the inferior colliculus (ICO), a key region critical for auditory processing.
“Similarly, the only midbrain structure that expands significant is the inferior colliculus (Fig. 4a,b, ICO)—a key region critical for auditory processing.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth temporal association cortex (TAC) and paraventricular nucleus of the thalamus (PVT) differ markedly in correlations between cases and controls for CFA (PVT rho is −0.38 for cases and +0.44 for controls).
“Both temporal association cortex (TAC) and the paraventricular nucleus of the thalamus (PVT) also differ markedly (Fig. 7c, where rhois −0.38 for cases and +0.44 for controls).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe loss of volume of the corticofugal projects in the cst strongly supports the finding of covariation, as does the 11% loss of FA signal in this tract.
“The loss of volume of the corticofugal projects in the cst that is mainly made up of large descending layer 5 axons (Fig. 6g, cst) strongly supports this finding, as does the 11% loss of FA signal in this vital tract (Fig. 6j).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA subset of 56 ROIs has reversed polarities of correlations of fear acquisition and volume between cases and controls, but only 13 ROIs for fear memory.
“A subset of 56 ROIs has reversed polarities of correlations of fear acquisition and volume between cases and controls (e.g., Fig. 7c,e) but only 13 ROIs for fear memory.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe volume reductions in diencephalic, midbrain, and hindbrain ROIs are just as strong and just as specific as the volume expansions in most telencephalic regions.
“The volume reductions in diencephalic, midbrain, and hindbrain ROIs are just as strong and just as specific as the volume expansions in most telencephalic regions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe authors reviewed delineations of VCS and recounted all cases and controls and could not identify any operational errors.
“We have reviewed the delineations of VCS and recounted all cases and controls, and we could not identify any operational errors.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationRegions that gain volume correspond roughly to Swanson's dorsolateral subsystem that mediates voluntary behaviors and cognition, whereas regions that lose volume correspond to the ventromedial subsystem that modulates affective and homeostatic functions.
“Regions that gain volume correspond roughly to Swanson’s dorsolateral subsystem that mediates voluntary behaviors and cognition, whereas regions that lose volume correspond to the ventromedial subsystem that modulates affective and homeostatic functions45.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Sokoloff, L. et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897–916 (1977). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCortical areas are 250 μm thicker in presymptomatic carriers of PSEN1 mutations than in controls at early prodromal stages, but are 250 μm thinner at late stages of disease.
“particularly the finding that cortical areas are 250 μm thicker in presymptomatic carriers of PSEN1 mutations than in controls at early prodromal stages, but are 250 μm thinner at late stages of disease (see figure 5 of Ref46).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Schwartz, W. J. & Gainer, H. Suprachiasmatic nucleus: use of 14C-labeled deoxyglucose uptake as a functional marker. Science 197, 1089–1091 (1977). source
May combine two claims.
InterpretationcitationThe rostro-caudal difference may reflect cortical swelling in the prodromal phase that is also detected in human carriers of aggressive PSEN1 mutations.
“This rostro-caudal difference may reflect cortical swelling in the prodromal phase that is also detected in human carriers of aggressive PSEN1 mutations46.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Schwartz, W. J. & Gainer, H. Suprachiasmatic nucleus: use of 14C-labeled deoxyglucose uptake as a functional marker. Science 197, 1089–1091 (1977). source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe consistency of the apparent swelling of most cortical regions may reflect inflammatory responses downstream of many possible transgene effects, including perhaps elevated β amyloid levels.
“The consistency of the apparent swelling of most cortical regions may reflect inflammatory responses downstream of many possible transgene effects, including perhaps elevated β amyloid levels.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataWe manually checked consistency of MRH-driven delineations and compared our boundaries to conventional stereological resources and stereological data.
“We have manually checked consistency of MRH-driven delineations (e.g., Figs 2, 3) and compared our boundaries to conventional stereological resources and stereological data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll experiments using live mice were carried out in accordance with AAALAC standards and NIH Guide, and the protocol was approved by IACUC.
“All experiments using live mice were carried out at University of Tennessee Health Science Center in accordance with standards of the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC), as well as recommendations of the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The protocol was approved by the Institutional Animal Care and Use”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe overall ANOVA model evaluates sources of variance of fractional volumes as a function of transgene status, genetic background, sex, and MRI scanner.
“The overall ANOVA model used in most analyses (Fig. 4) evaluates sources of variance of fractional volumes (bilateral sums of ROIs) as a function of transgene status, genetic background, sex, and MRI scanner.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenDistortions in light-sheet processed tissue and images were removed by aligning the NeuN (561 nm) volume to the original DWI volume of the same individual.
“The inevitable distortions in light-sheet processed tissue and images were removed by aligning the NeuN (561 nm) volume to the original DWI volume of the same individual (Fig. 1h).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe combination of high resolution and high delineation precision has increased statistical power and enabled us to detect volumetric changes previously hidden by measurement noise.
“The combination of high resolution and high delineation precision has increased statistical power and enabled us to detect volumetric changes previously hidden by measurement noise.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationCVs are biased downward by about 25% with a sample size of only two, but we did not apply this correction because the technical components of CVs are overestimated by biological sources of asymmetry.
“Like standard deviations, CVs are biased downward by about 25% with a sample size of only two93, but we did not apply this correction because the technical components of CVs are overestimated by biological sources of asymmetry.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Gurland, J. & Tripathi, R. C. A simple approximation for unbiased estimation of the standard deviation. Am. Stat. 25, 30–32 (1971). source
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe percentage of time spent freezing during the CFM test was used as a measure of CFM, a measure known to be dependent on hippocampal function.
“The percentage of time spent freezing during this trial was used as a measure of CFM, a measure known to be dependent on hippocampal function84.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] Chen, C., Kim, J. J., Thompson, R. F. & Tonegawa, S. Hippocampal lesions impair contextual fear conditioning in two strains of mice. Behav. Neurosci. 110, 1177–1180 (1996). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenMouse models have benefits by enabling tight control of genetics, age, and diet, and because the impact of treatments can be evaluated within two years or less.
“Mouse models have obvious benefits by enabling tight control of genetics, age, and diet, and because the impact of treatments can be evaluated within two years or less.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataStatistical significance thresholds were set at P of 0.01, 0.05, and 0.1, corrected for 22 tests of ROIs.
“Estimates of statistical significance used thresholds at P of 0.01, 0.05, and 0.1, corrected for 22 tests of ROIs (Fig. 6f-l).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningTo minimize bias from individual specimens, a pairwise minimum deformation template (MDT) was generated using a hybrid image for all individuals of a particular genetic background type.
“To minimize bias from individual specimens, a pairwise minimum deformation template (MDT) was generated using a hybrid image for all individuals of a particular genetic background type (e.g., Fig. 3a,b).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThis registration step is critical due to the small voxel size and the strength of the gradients.
“This step is critical due to the small voxel size and the strength of the gradients (up to 50 times stronger than standard clinical DTI).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationBenjamini-Hochberg or Bonferroni corrections were used to define P values at different FDR thresholds.
“Benjamini-Hochberg (BH) corrections34 or Bonferroni corrections were used to define P values at different FDRs thresholds (Fig. 3d, Fig. 4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995). source
Classified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningFemale transgenic mice were always used as dams so that the mitochondrial genome of all F1 hybrid was constant, and to control for strain-specific differences in pre- and postnatal parent-of-origin effects.
“Female transgenic mice were always used as dams so that the mitochondrial genome of all F1 hybrid was constant, and to control for strain-specific differences in pre- and postnatal parent-of-origin effects.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningWe formally can only claim good precision of delineation rather than accuracy.
“Note that we formally can only claim good precision of delineation rather than accuracy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe scanner was upgraded in 2023 to an MR Solutions console-a factor controlled in all statistical analyses.
“The system was upgraded in 2023 to an MR Solutions console—a factor controlled in all statistical analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThere is a strong correlation between aβ plaque levels and NeuN+ cell densities in most ROIs in 5×FAD cases that is probably caused by common penetration patterns of these two antibodies.
“2. a strong correlation between aβ plaque levels and NeuN+ cell densities in most ROIs in 5×FAD cases that is probably caused by common penetration patterns of these two antibodies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThere is an implausible increase in NeuN+ cells in visual cortex that is either due to sampling error or lack of neuronal specificity of antibody binding in 5×FAD cases.
“There are two exceptions: 1. an implausible increase in NeuN+ cells in visual cortex that is either due to sampling error or lack of neuronal specificity of antibody binding in 5×FAD cases”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMajor fiber tracts, ventricles and blood vessels are easily resolved in the MRH 3D volumes.
“Major fiber tracts, ventricles and blood vessels are easily resolved.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
There is not much systematic case-control data on structural effects of Alzheimer's disease in either humans or mice, particularly on the integrity of subcortical regions as a function of AD mutation type, sex, age of onset of behavioral symptoms, environment, or treatment history.
“Another problem is that there is not much systematic case-control data on structural effects of AD in either humans or mice—particularly on the integrity of subcortical regions as a function of AD mutation type, sex, age of onset of behavioral symptoms, environment, or treatment history.”
The paper relies on this without support.
The 5×FAD transgene in mice models the structural and behavioral effects of Alzheimer's disease.
“We mapped the global impact of mutations in APP and PSEN1 across 231 precisely delineated regions of interest (ROIs) by diffusion tensor MRI at 25 μm resolution using diverse 5×FAD AD-BXD hybrid male and female mice at 14 months.”
The paper relies on this without support.
The increase in volumes of ROIs has not previously been reported in 5×FAD mice.
“The increase in volumes of ROIs has not previously been reported in 5×FAD mice.”
The paper relies on this without support.
The gradients in volumetric effects—rostral expansion and caudal shrinkage, lateral expansion and medial shrinkage—are novel.
“The gradients in volumetric effects—rostral expansion and caudal shrinkage, lateral expansion and medial shrinkage—are also novel and leads to key questions about ontogenetic, molecular, and cellular processes of AD vulnerability.”
The paper relies on this without support.
The DMBA coordinate space is a consensus for the C57BL/6J strain at stereotaxic precision.
“The DMBA coordinate space is a consensus for the C57BL/6J strain at stereotaxic precision.”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(3, 53) = 2.8reported p < .05 · recomputed p = .049
“F(3,53) = 2.8, p < .05”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The list of seven motor-related ROIs contains eight
MinorThe discussion calls these the remaining seven regions or tracts, but names eight: ION, MRN, MBM, PNM, PRT, RED, TMN, and cst.
“the remaining seven are motor-related nuclei and tracts”
“(ION, MRN, MBM, PNM, PRT, RED, TMN, and cst)”
A reported negative correlation has a positive coefficient
MinorThe reported coefficient and its ±0.14 range are positive, contrary to the description of the correlation as negative.
“do have a modest negative correlation of Aβ levels with volumes”
“ρ = 0.32 ± 0.14, Supplementary Table 9d”
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423 · see citing works
Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient
Stejskal, E. O., & Tanner, J. E. (1965) · The Journal of Chemical Physics · doi:10.1063/1.1695690 · Cited by 8,239 · see citing works
Sparse MRI: The application of compressed sensing for rapid MR imaging
Lustig, M., Donoho, D., & Pauly, J. M. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21391 · Cited by 6,952 · see citing works
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000 · see citing works
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · see citing works
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Shin, L. M., & Liberzon, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.83 · Cited by 2,083 · see citing works
cocor: A Comprehensive Solution for the Statistical Comparison of Correlations
Diedenhofen, B., & Musch, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121945 · Cited by 1,919 · see citing works
High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity
Tuch, D. S., Reese, T. G., Wiegell, M. R., Makris, N., Belliveau, J. W., & Wedeen, V. J. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10268 · Cited by 1,548 · see citing works
Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review
Basser, P. J., & Jones, D. K. (2002) · NMR in Biomedicine · doi:10.1002/nbm.783 · Cited by 1,484 · see citing works
The Allen Mouse Brain Common Coordinate Framework: A 3D Reference Atlas
Wang, Q., Ding, S., Li, Y., Royall, J. J., Feng, D. H., Lesnar, P., Graddis, N., Naeemi, M., Facer, B. A. C., Ho, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.007 · Cited by 1,410 · see citing works
Consensus classification of posterior cortical atrophy
Crutch, S. J., Schott, J. M., Rabinovici, G. D., Murray, M., Snowden, J. S., van der Flier, W. M., Dickerson, B. C., Vandenberghe, R., Ahmed, S., Bak, T. H., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.014 · Cited by 665 · see citing works
The Insight ToolKit image registration framework
Avants, B. B., Tustison, N. J., Stauffer, M., Song, G., Wu, B., & Gee, J. C. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00044 · Cited by 658 · see citing works
Gordon, B. A., Blazey, T. M., Su, Y., Hari-Raj, A., Dincer, A., Flores, S., Christensen, J., McDade, E., Wang, G., Xiong, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30028-0 · Cited by 602 · see citing works
At the interface of sensory and motor dysfunctions and Alzheimer’s disease.
Albers, M. W., Gilmore, G. C., Kaye, J., Murphy, C., Wingfield, A., Bennett, D. A., Boxer, A. L., Buchman, A. S., Cruickshanks, K. J., Devanand, D. P., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.514 · Cited by 589 · see citing works
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · see citing works
NTU-90: A high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction
Yeh, F.-C. F., & Tseng, W. I. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.021 · Cited by 509 · see citing works
The paraventricular thalamus controls a central amygdala fear circuit
Penzo, M. A., Robert, V., Tucciarone, J., De Bundel, D., Wang, M., Van Aelst, L., Darvas, M., Parada, L. F., Palmiter, R. D., He, M., et al. (2015) · Nature · doi:10.1038/nature13978 · Cited by 506 · see citing works
Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
Ryman, D. C., Acosta-Baena, N., Aisen, P. S., Bird, T., Danek, A., Fox, N. C., Goate, A., Frommelt, P., Ghetti, B., Langbaum, J. B. S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000596 · Cited by 502 · see citing works
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease.
Forner, S., Kawauchi, S., Balderrama-Gutierrez, G., Kramár, E. A., Matheos, D. P., Phan, J., Javonillo, D. I., Tran, K. M., Hingco, E., da Cunha, C., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-01054-y · Cited by 501 · see citing works
NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker
Gusel’nikova, V. V., & Korzhevskiy, D. E. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-2-42-47 · Cited by 487 · see citing works
Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems
Murray, E. M., Cho, J., Goodwin, D., Ku, T., Swaney, J., Kim, S., Choi, H., Park, Y.-G., Park, J. Y., Hubbert, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.025 · Cited by 470 · see citing works
Williams, R. W., & RAKIC, P. T. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902780305 · Cited by 426 · see citing works
Self-citationEimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425 · see citing works
Olfactory and other sensory impairments in Alzheimer disease
Murphy, C. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0097-5 · Cited by 425 · see citing works
Protection of tissue physicochemical properties using polyfunctional crosslinkers
Park, Y.-G., Sohn, C. H., Chen, R., McCue, M., Yun, D. H., Drummond, G. T., Ku, T., Evans, N. B., Oak, H. C., Trieu, W., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4281 · Cited by 421 · see citing works
Kim, K. K., Adelstein, R. S., & Kawamoto, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052969 · Cited by 398 · see citing works
Aggleton, J. P., Pralus, A., Nelson, A. J. D., & Hornberger, M. (2016) · Brain · doi:10.1093/brain/aww083 · Cited by 378 · see citing works
Suprachiasmatic Nucleus: Use of <sup>14</sup> C-Labeled Deoxyglucose Uptake as a Functional Marker
Schwartz, W. J., & Gainer, H. (1977) · Science · doi:10.1126/science.887940 · Cited by 358 · see citing works
Alzheimer's disease: From immunotherapy to immunoprevention
Jucker, M., & Walker, L. C. (2023) · Cell · doi:10.1016/j.cell.2023.08.021 · Cited by 353 · see citing works
Alzheimer's disease affects limbic nuclei of the thalamus
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00305867 · Cited by 328 · see citing works
Oblak, A. L., Lin, P. B., Kotredes, K. P., Pandey, R. S., Garceau, D., Williams, H. M., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.713726 · Cited by 325 · see citing works
<i>APOE</i> Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
Belloy, M. E., Andrews, S. J., Le Guen, Y., Cuccaro, M., Farrer, L. A., Napolioni, V., & Greicius, M. D. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3599 · Cited by 320 · see citing works
The amyloid precursor protein: A biochemical enigma in brain development, function and disease
Nalivaeva, N. N., & Turner, A. J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.010 · Cited by 271 · see citing works
Genetic Background Limits Generalizability of Genotype-Phenotype Relationships
Sittig, L. J., Carbonetto, P. S., Engel, K. A., Krauss, K. S., Barrios-Camacho, C. M., & Palmer, A. A. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.013 · Cited by 247 · see citing works
Sturman, O., von Ziegler, L., Schläppi, C., Akyol, F., Privitera, M., Slominski, D., Grimm, C., Thieren, L., Zerbi, V., Grewe, B. F., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0776-y · Cited by 243 · see citing works
Stochastic electrotransport selectively enhances the transport of highly electromobile molecules
Kim, S., Cho, J., Murray, E. M., Bakh, N., Choi, H., Ohn, K., Ruelas, L., Hubbert, A., McCue, M., Vassallo, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510133112 · Cited by 239 · see citing works
Ryan, N. S., Nicholas, J. M., Weston, P. S. J., Liang, Y., Lashley, T., Guerreiro, R. J., Adamson, G., Kenny, J., Beck, J. A., Chávez‐Gutiérrez, L., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30193-4 · Cited by 238 · see citing works
Reproducibility and replicability of rodent phenotyping in preclinical studies
Kafkafi, N., Agassi, J., Chesler, E. J., Crabbe, J. C., Crusio, W. E., Eilam, D., Gerlai, R., Golani, I., Gomez-Marin, A., Heller, R., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.003 · Cited by 215 · see citing works
Self-citationHistology by magnetic resonance microscopy.
Johnson, G. A., Benveniste, H., Black, R. D., Hedlund, L. W., Maronpot, R. R., & Smith, B. R. (1993) · PubMed · Cited by 214 · see citing works
Self-citationAncestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
Rajabli, F., Feliciano, B. E., Celis, K., Hamilton-Nelson, K. L., Whitehead, P. L., Adams, L. D., Bussies, P. L., Manrique, C. P., Rodriguez, A., Rodriguez, V., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007791 · Cited by 206 · see citing works
Ryan, N. S., Keihaninejad, S., Shakespeare, T. J., Lehmann, M., Crutch, S. J., Malone, I. B., Thornton, J. S., Mancini, L., Hyare, H., Yousry, T., et al. (2013) · Brain · doi:10.1093/brain/awt065 · Cited by 205 · see citing works
Neuner, S. M., Heuer, S. E., Huentelman, M. J., O’Connell, K. M. S., & Kaczorowski, C. C. (2019) · Neuron · doi:10.1016/j.neuron.2018.11.040 · Cited by 202 · see citing works
Self-citationA platform for experimental precision medicine: The extended BXD mouse family
Ashbrook, D. G., Arends, D., Prins, P., Mulligan, M. K., Roy, S., Williams, E. G., Lutz, C. M., Valenzuela, A., Bohl, C. J., Ingels, J. F., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2020.12.002 · Cited by 171 · see citing works
Self-citationAmygdala, hippocampus and discriminative fear conditioning to context
Antoniadis, E. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00121-7 · Cited by 170 · see citing works
Bernier, B. E., Lacagnina, A. F., Ayoub, A., Shue, F., Zemelman, B. V., Krasne, F. B., & Drew, M. R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3029-16.2017 · Cited by 168 · see citing works
Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Habes, M., Grothe, M. J., Tunc, B., McMillan, C., Wolk, D. A., & Davatzikos, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.016 · Cited by 167 · see citing works
Müller, C., & Remy, S. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2745-2 · Cited by 167 · see citing works
Hippocampal lesions impair contextual fear conditioning in two strains of mice.
Chen, C., Kim, J. J., Thompson, R. F., & Tonegawa, S. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.5.1177 · Cited by 148 · see citing works
Joint mouse–human phenome-wide association to test gene function and disease risk
Wang, X., Pandey, A. K., Mulligan, M. K., Williams, E. G., Mozhui, K., Li, Z., Jovaisaite, V., Quarles, L. D., Xiao, Z., Huang, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10464 · Cited by 147 · see citing works
Self-citationIncreased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers
Fortea, J., Sala‐Llonch, R., David Bartrés-faz, A., Bosch, B., Lladó, A., Bargalló, N., Molinuevo, J. L., & Sánchez‐Valle, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100678 · Cited by 146 · see citing works
Neuroimaging of fear-associated learning
Greco, J. A., & Liberzon, I. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.255 · Cited by 145 · see citing works
Hippocampal lesions impair contextual fear conditioning in two strains of mice.
Chen, C., Kim, J. J., Thompson, R. F., & Tonegawa, S. (1996) · Behavioral Neuroscience · doi:10.1037//0735-7044.110.5.1177 · Cited by 142 · see citing works
The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning
Keifer, O. P., Hurt, R. C., Ressler, K. J., & Marvar, P. J. (2015) · Physiology · doi:10.1152/physiol.00058.2014 · Cited by 124 · see citing works
A Simple Approximation for Unbiased Estimation of the Standard Deviation
Gurland, J., & Tripathi, R. C. (1971) · The American Statistician · doi:10.1080/00031305.1971.10477279 · Cited by 117 · see citing works
Hernández-Rabaza, V., Hontecillas-Prieto, L., Velázquez-Sánchez, C., Ferragud, A., Pérez-Villaba, A., Arcusa, A., Barcia, J. A., Trejo, J. L., & Canales, J. J. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.06.008 · Cited by 114 · see citing works
Fear conditioning and the basolateral amygdala
Sun, Y., Gooch, H., & Sah, P. (2020) · F1000Research · doi:10.12688/f1000research.21201.1 · Cited by 104 · see citing works
Andersen, J. V., Skotte, N. H., Christensen, S. K., Polli, F. S., Shabani, M., Markussen, K. H., Haukedal, H., Westi, E. W., Diaz-delCastillo, M., Sun, R. C., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04237-y · Cited by 104 · see citing works
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96 · see citing works
In search of common developmental and evolutionary origin of the claustrum and subplate
Bruguier, H., Suarez, R., Manger, P., Hoerder‐Suabedissen, A., Shelton, A. M., Oliver, D. K., Packer, A. M., Ferran, J. L., García‐Moreno, F., Puelles, L., et al. (2020) · Journal of Comparative Neurology · doi:10.1002/cne.24922 · Cited by 84 · see citing works
Negash, S., Wilson, R. S., Leurgans, S., Wolk, D., Schneider, J., Buchman, A., Bennett, D., & Arnold, S. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990157 · Cited by 81 · see citing works
Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
Macdonald, I. R., DeBay, D. R., Reid, G. A., O’Leary, T. P., Jollymore, C. T., Mawko, G., Burrell, S., Martin, E., Bowen, C. V., Brown, R. E., et al. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140505111354 · Cited by 79 · see citing works
Aging-associated sensory decline and Alzheimer’s disease
Hong, S., Baek, S.-H., Lai, M. K. P., Arumugam, T. V., & Jo, D.-G. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00776-y · Cited by 76 · see citing works
St-Jean, S., Coupé, P., & Descoteaux, M. (2016) · Medical Image Analysis · doi:10.1016/j.media.2016.02.010 · Cited by 74 · see citing works
Whole mouse brain structural connectomics using magnetic resonance histology
Wang, N., Anderson, R. J., Badea, A., Cofer, G., Dibb, R., Qi, Y., & Johnson, G. A. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1750-x · Cited by 71 · see citing works
Self-citationA natural mutator allele shapes mutation spectrum variation in mice
Sasani, T. A., Ashbrook, D. G., Beichman, A. C., Lu, L., Palmer, A. A., Williams, R. W., Pritchard, J. K., & Harris, K. (2022) · Nature · doi:10.1038/s41586-022-04701-5 · Cited by 64 · see citing works
Self-citationEvangelio, M., García-Amado, M., & Clascá, F. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00027 · Cited by 61 · see citing works
Ratigan, H. C., Krishnan, S., Smith, S., & Sheffield, M. E. J. (2023) · Nature Communications · doi:10.1038/s41467-023-42429-6 · Cited by 60 · see citing works
Shin, J., Park, S., Lee, H., & Kim, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-81304-6 · Cited by 56 · see citing works
Merged magnetic resonance and light sheet microscopy of the whole mouse brain
Johnson, G. A., Tian, Y., Ashbrook, D. G., Cofer, G. P., Cook, J. J. H., Gee, J. C., Hall, A., Hornburg, K. J., Kaczorowski, C. C., Qi, Y. P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218617120 · Cited by 56 · see citing works
Self-citationAnderson, R. J., Cook, J. J. H., Delpratt, N. A., Nouls, J. C., Gu, B., McNamara, J. O., Avants, B., Johnson, G. A., & Badea, A. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9410-0 · Cited by 52 · see citing works
Self-citationWang, N., Anderson, R. J., Ashbrook, D. G., Gopalakrishnan, V., Park, Y., Priebe, C. E., Qi, Y. P., Laoprasert, R., Vogelstein, J. T., Williams, R. W., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117274 · Cited by 51 · see citing works
Self-citationStress Granules Contain Rbfox2 with Cell Cycle-related mRNAs
Park, C., Choi, S., Kim, Y.-E., Lee, S., Park, S.-H., Adelstein, R. S., Kawamoto, S., & Kim, K. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-11651-w · Cited by 49 · see citing works
Sensory processing deficits and related cortical pathological changes in Alzheimer’s disease
Zhang, N. K., Zhang, S. K., Zhang, L. I., Tao, H. W., & Zhang, G.-W. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1213379 · Cited by 49 · see citing works
Ashbrook, D. G., Williams, R. W., Lu, L., Stein, J. L., Hibar, D. P., Nichols, T. E., Medland, S. E., Thompson, P. M., & Hager, R. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-850 · Cited by 49 · see citing works
Self-citationGenetic Control of Interconnected Neuronal Populations in the Mouse Primary Visual System
Seecharan, D. J., Kulkarni, A. L., Lu, L., Rosen, G. D., & Williams, R. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11178.2003 · Cited by 43 · see citing works
Self-citationSeptal GABAergic inputs to CA1 govern contextual memory retrieval
Sans-Dublanc, A., Razzauti, A., Desikan, S., Pascual, M., de la Rocha, J., Monyer, H., & Sindreu, C. B. (2020) · Science Advances · doi:10.1126/sciadv.aba5003 · Cited by 41 · see citing works
Thalamic nuclei changes in early and late onset Alzheimer's disease
Forno, G., Saranathan, M., Contador, J., Guillen, N., Falgàs, N., Tort-Merino, A., Balasa, M., Sanchez-Valle, R., Hornberger, M., & Lladó, A. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100084 · Cited by 39 · see citing works
Kotredes, K. P., Pandey, R. S., Persohn, S. A., Elderidge, K., Burton, C. P., Miner, E. W., Haynes, K. A., dos Santos, D. F. D. S., Williams, S. G., Heaton, N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13828 · Cited by 38 · see citing works
The cerebellum regulates fear extinction through thalamo-prefrontal cortex interactions in male mice
Frontera, J. L., Sala, R. W., Georgescu, I. A., Baba Aissa, H., d’Almeida, M. N., Popa, D., & Léna, C. (2023) · Nature Communications · doi:10.1038/s41467-023-36943-w · Cited by 38 · see citing works
GeneNetwork: framework for web-based genetics
Sloan, Z., Arends, D., W. Broman, K., Centeno, A., Furlotte, N., Nijveen, H., Yan, L., Zhou, X., W. Williams, R., & Prins, P. (2016) · The Journal of Open Source Software · doi:10.21105/joss.00025 · Cited by 37 · see citing works
Arnold, S. E., Hyman, B. T., Betensky, R. A., & Dodge, H. H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14063 · Cited by 36 · see citing works
Neuner, S. M., Heuer, S. E., Zhang, J., Philip, V. M., & Kaczorowski, C. C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00035 · Cited by 31 · see citing works
Self-citationExperimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae
Rother, C., Uhlmann, R. E., Müller, S. A., Schelle, J., Skodras, A., Obermüller, U., Häsler, L. M., Lambert, M., Baumann, F., Xu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34538-5 · Cited by 28 · see citing works
Heuer, S. E., Neuner, S. M., Hadad, N., O’Connell, K. M. S., Williams, R. W., Philip, V. M., Gaiteri, C., & Kaczorowski, C. C. (2020) · Learning & Memory · doi:10.1101/lm.051839.120 · Cited by 26 · see citing works
Self-citationExpanding the canon: An inclusive neurobiology of thalamic and subthalamic fear circuits
Venkataraman, A., & Dias, B. G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109380 · Cited by 26 · see citing works
O’Connell, K. M. S., Ouellette, A. R., Neuner, S. M., Dunn, A. R., & Kaczorowski, C. C. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12603 · Cited by 23 · see citing works
Self-citationHerding cats: the sociology of data integration
Williams, R. W. (2009) · Frontiers in Neuroscience · doi:10.3389/neuro.01.016.2009 · Cited by 22 · see citing works
Self-citationGenetic dissection of the mouse CNS using magnetic resonance microscopy
Badea, A., Johnson, G. A., & Williams, R. W. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832d9b86 · Cited by 22 · see citing works
Self-citationSwanson, L. W., Hahn, J. D., & Sporns, O. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017733117 · Cited by 20 · see citing works
Westi, E. W., Molhemi, S., Hansen, C. T., Skoven, C. S., Knopper, R. W., Ahmad, D., Rindshøj, M. B., Ameen, A. O., Hansen, B., Kohlmeier, K. A., et al. (2024) · Biomolecules · doi:10.3390/biom14101294 · Cited by 20 · see citing works
Detecting the effect of genetic diversity on brain composition in an Alzheimer’s disease mouse model
Gurdon, B., Yates, S. C., Csucs, G., Groeneboom, N. E., Hadad, N., Telpoukhovskaia, M., Ouellette, A., Ouellette, T., O’Connell, K. M. S., Singh, S., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06242-1 · Cited by 15 · see citing works
Self-citationZhang, Y., Wang, Z., Ju, J., Liao, J., & Zhou, Q. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200151 · Cited by 14 · see citing works
Crombé, A., Nicolas, R., Richard, N., Tourdias, T., & Hiba, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-15511-0 · Cited by 13 · see citing works
Effects of Species-Specific Genetics on Alzheimer’s Mouse Models
Hyman, B. T., & Tanzi, R. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.021 · Cited by 11 · see citing works
The Duke Mouse Brain Atlas: MRI and light sheet microscopy stereotaxic atlas of the mouse brain
Mansour, H., Azrak, R., Cook, J. J., Hornburg, K. J., Qi, Y., Tian, Y., Williams, R. W., Yeh, F.-C., White, L. E., & Johnson, G. A. (2025) · Science Advances · doi:10.1126/sciadv.adq8089 · Cited by 11 · see citing works
Self-citationTian, Y., Johnson, G. A., Williams, R. W., & White, L. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223226 · Cited by 9 · see citing works
Self-citationContextual Fear Learning and Extinction in the Primary Visual Cortex of Mice
Xie, X., Gong, S., Sun, N., Zhu, J., Xu, X., Xu, Y., Li, X., Du, Z., Liu, X., Zhang, J., et al. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00889-8 · Cited by 7 · see citing works
Murdy, T. J., Dunn, A. R., Singh, S., Telpoukhovskaia, M. A., Zhang, S., White, J. K., Kahn, I., Febo, M., & Kaczorowski, C. C. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1033975 · Cited by 6 · see citing works
Self-citationRestoring morphology of light sheet microscopy data based on magnetic resonance histology
Tian, Y., Cook, J. J. H., & Johnson, G. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1011895 · Cited by 5 · see citing works
Self-citationRajabli, F., Seixas, A. A., Akgün, B., Adams, L. D., Inciute, J. D., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231116 · Cited by 4 · see citing works
Gómez-Pascual, A., Glikman, D. M., Ng, H. X., Tomkins, J. E., Lu, L., Xu, Y., Ashbrook, D. G., Kaczorowski, C. C., Kempermann, G., KILLMAR, J. T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.22.567373 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Levene, H. in Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling (eds Orkin, I. & Hotelling, H.) 278–292 (Stanford University Press, 1960).
Cited by
Still being checked.
- Authors
- Tian, Y., Hornburg, K., Austin, W., Cook, J. J., Qi, Y., White, L. E., Killmar, J. T., Kaczorowski, C. C., Ashbrook, D. G., Johnson, G. A., & Williams, R. W.
- Affiliations
- Duke Medical Center (US)
- University of Tennessee Health Science Center (US)
- University of Michigan (US)
- Duke University (US)
- Corresponding author
- Ashbrook, David G.
- Johnson, G. Allan
- Williams, Robert W.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2026-02-26
- Volume
- 29
- Issue
- 4
- Pages
- 1007-1020
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC13185701
- OpenAlex
- W7131681600
- Semantic Scholar
- 34ea792ea991f7127421b389d0b2e0e2affb63f2
- Cited by
- 1
- References
- 103
- Citations by year
- 2026: 1
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (5r01ns120954-04, 5r01ag070913-05)
- National Institute on Aging (R01AG057914)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, brain structure, brain volume changes, APP mutations, PSEN1 mutations, 5xFAD mice, diffusion tensor imaging, brainstem, white matter tracts, hippocampus, amygdala, neocortex, thalamus, sex differences, fear acquisition, contextual memory, individual differences in behavior
- MeSH terms
- Alzheimer Disease, Animals, Behavior, Animal, Brain, Brain Mapping, Disease Models, Animal, Fear, Female, Magnetic Resonance Imaging, Male, Mice, Transgenic, Amyloid beta-Protein Precursor, Mice, Presenilin-1, Diffusion Tensor Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-24.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-24.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review